Sonoma Pharmaceuticals, Inc. Financial Ratios — SNOA Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-88.83	-53.24	22.39	-45.78	-70.44	47.24	-64.16	-70.11	-22.81	-26.74	-30.07	-29.37	-31.22	-24.32	-22.96
Return on Capital (%)	- -	- -	-3.55	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	-66.46	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	68.38	69.52	61.44	52.61	28.26	44.19	43.88	46.81	45.3	35.21	31.62	33.73	37.26	38.25	37.97
EBITDA Margin (%)	-48.19	-20.1	-42.19	-46.24	-154.45	-99.23	-82.24	-56.96	-39.48	-17.3	-45.15	-33.49	-35.53	-25	-11.89
Operating Margin (%)	-50.75	-21.84	-44.27	-48.07	-157.05	-101.16	-85.18	-59.35	-41.22	-18.51	-46.62	-34.43	-36.91	-25.97	-12.6
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-57.51	-35.15	27.33	-59.21	-157.16	-100.87	-85.71	-59.78	-19.77	-20.95	-42.9	-39.06	-39.51	-20.35	-17.51
Profit Margin (%)	-57.51	-35.15	27.33	-59.21	-108.46	72.31	-86.01	-62.19	-18.45	-21.2	-40.28	-38.81	-37.97	-24.2	-16.26
Net Income to Common Margin (%)	-57.51	-42.02	27.33	-59.21	-108.46	72.31	-86.01	-62.19	-18.45	-21.2	-40.28	-38.81	-37.97	-24.2	-16.26
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	16.36	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Total Debt	3	2	- -	- -	- -	- -	1	- -	1	3	1	1	1	- -	1
ST Debt	1	1	- -	- -	- -	- -	- -	- -	1	1	1	1	1	- -	- -
LT Debt	2	1	- -	- -	- -	- -	- -	- -	- -	2	- -	- -	- -	- -	- -
Total Debt/EBITDA	-0.53	-0.62	-0.03	-0.01	-0.01	-0.03	-0.04	-0.04	-0.12	-0.83	-0.24	-0.19	-0.13	-0.09	-0.36
Net Debt/EBITDA	0.02	1.92	0.92	0.94	0.51	1.36	0.72	0.31	0.45	0.72	1.16	0.76	0.62	1.44	0.94
Total Debt/EBIT	-0.5	-0.57	-0.02	-0.01	-0.01	-0.03	-0.04	-0.04	-0.12	-0.78	-0.23	-0.19	-0.13	-0.08	-0.34
Net Debt/EBIT	0.02	1.77	0.88	0.91	0.5	1.33	0.69	0.3	0.43	0.67	1.12	0.74	0.6	1.39	0.88
EBITDA to Interest Expense	-6.6	-2.81	-5.45	-2,135.33	-4,823.33	-4,242	-342.48	-327.42	-442.38	-268.5	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-6.96	-3.04	-5.93	-2,181.67	-4,938.33	-4,373.33	-347.15	-330.45	-455.25	-283.42	- -	- -	- -	- -	- -
EBIT to Interest Expense	-6.95	-3.05	-5.72	-2,219.67	-4,904.67	-4,324.67	-354.72	-341.15	-461.88	-287.42	- -	- -	- -	- -	- -
Interest Expense	1	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-1,688.11	-1,096.25	-644.55	-945.05	-1,103.92	-562.08	-819.74	-1,171.35	-1,204.07	-1,196.2	-978.3	-1,167.57	-1,318.51	-1,444.58	-1,439.69
Long-Term Debt/Equity (%)	- -	16.56	0.03	- -	- -	0.99	1.15	0.11	4.18	34.29	3.55	2.03	1.42	0.61	15.15
Long-Term Debt/Capital (%)	-1.41	-0.5	- -	- -	- -	-0.15	-0.11	-0.01	-0.13	-1.04	-0.17	-0.09	-0.04	-0.01	-0.23
Long-Term Debt/Total Assets (%)	23.27	5.38	0.02	- -	- -	0.84	0.92	0.08	1.61	12.27	1.64	1	0.59	0.2	3.36
Total Debt/Equity (%)	-373.16	47.41	1.22	0.72	1.12	1.91	3.61	4.53	15.11	49.88	15.72	10.64	9.91	6.91	27.21
Total Debt/Capital (%)	-2.51	-1.42	-0.11	-0.06	-0.07	-0.29	-0.35	-0.28	-0.49	-1.51	-0.75	-0.45	-0.31	-0.15	-0.42
Total Debt/Total Assets (%)	41.32	15.4	0.71	0.58	0.83	1.61	2.88	3.29	5.84	17.85	7.25	5.23	4.12	2.23	6.03
Net Debt to Equity	12.9	-146.17	-44.21	-50.18	-72.53	-80.69	-63.97	-31.99	-57.08	-43.15	-75.75	-42.48	-45.71	-116.84	-70.34
Net Debt/Capital (%)	0.08	4.15	3.83	4.08	4.6	10.8	5.87	1.95	1.8	1.28	3.46	1.76	1.42	2.54	1.07
EBITDA	-6	-3	-6	-6	-14	-13	-14	-11	-7	-3	-6	-4	-5	-4	-2
EBITDA-CapEx	-6	-3	-6	-7	-15	-13	-14	-11	-7	-3	-6	-5	-5	-4	-3
Operating Income (Loss)	-6	-3	-6	-7	-15	-13	-14	-11	-7	-3	-6	-5	-5	-4	-2

Liquidity (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Cash Ratio	0.71	1.54	0.72	2.38	2.1	5.31	3.09	1.03	0.78	1.03	1.27	1.03	0.84	1.31	0.5
Current Ratio	1.47	2.25	1.26	3.74	3.63	6.89	4.98	3.48	2.6	3.18	2.82	3.71	3.37	3.09	2.5
Quick Ratio	1.16	1.87	1.03	2.97	2.53	5.95	3.62	2.26	1.9	2.18	2.09	2.75	2.45	2.23	1.62
CFO/Avg Current Liab	-0.88	0.23	-0.77	-1.32	-2.85	-2.39	-3.8	-3.42	-1.1	-0.77	-0.86	-1.29	-0.64	-0.02	-0.88
Common Equity/Total Assets	-1,688.11	-1,096.25	-644.55	-945.05	-1,103.92	-562.08	-819.74	-1,171.35	-1,204.07	-1,196.2	-978.3	-1,167.57	-1,318.51	-1,444.58	-1,439.69
Long-Term Debt/Equity (%)	- -	16.56	0.03	- -	- -	0.99	1.15	0.11	4.18	34.29	3.55	2.03	1.42	0.61	15.15
Long-Term Debt/Capital (%)	-1.41	-0.5	- -	- -	- -	-0.15	-0.11	-0.01	-0.13	-1.04	-0.17	-0.09	-0.04	-0.01	-0.23
Long-Term Debt/Total Assets (%)	23.27	5.38	0.02	- -	- -	0.84	0.92	0.08	1.61	12.27	1.64	1	0.59	0.2	3.36
Total Debt/Equity (%)	-373.16	47.41	1.22	0.72	1.12	1.91	3.61	4.53	15.11	49.88	15.72	10.64	9.91	6.91	27.21
Total Debt/Capital (%)	-2.51	-1.42	-0.11	-0.06	-0.07	-0.29	-0.35	-0.28	-0.49	-1.51	-0.75	-0.45	-0.31	-0.15	-0.42
Total Debt/Total Assets (%)	41.32	15.4	0.71	0.58	0.83	1.61	2.88	3.29	5.84	17.85	7.25	5.23	4.12	2.23	6.03
CFO/Total Liabilities	-46.31	13.55	-56.03	-223.58	-238.77	-202.76	-320.59	-295.96	-51.37	-35.1	-41.86	-74.53	-27.87	-0.95	-36.2
CFO/CapEx	-12	4.47	-9.7	-48.16	-25.35	-20.73	-66.52	-117.17	-22.29	-18.87	-31.01	-22.87	-1,199	-1.1	-20.48
Altman's Z-Score	-21.88	-13.31	-7.43	-11.58	-14.91	-3.57	-9.66	-15.73	-16.19	-14.63	-12.75	-15.47	-17.82	-19.15	-18.52

Working Capital (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Accounts Receivable Turnover	6	8.01	7.82	8.38	6.19	7.09	9.14	7.56	4.81	5.5	4.84	5.33	4.66	5.57	8.21
Days Sales Outstanding	60.79	45.57	46.69	43.56	58.92	51.46	39.93	48.28	75.88	66.41	75.34	68.47	78.39	65.53	44.47
Inventory Turnover	4.78	4.84	5.07	5.27	4.49	3.75	3.68	3.22	3.51	5.12	3.33	3.19	2.87	3.13	3.69
Days Inventory Outstanding	76.35	75.38	72.02	69.21	81.38	97.31	99.29	113.48	104.04	71.23	109.75	114.56	127.38	116.54	98.92
Accounts Payable Turnover	5.72	5.85	6.95	8.25	6.09	6.01	7.91	8.42	5.16	6.47	5.14	7.24	10.84	11.56	8.94
Accounts Payable Turnover Days	63.77	62.42	52.5	44.25	59.89	60.78	46.15	43.37	70.68	56.37	70.98	50.39	33.66	31.57	40.85
Cash Conversion Cycle	73.37	58.52	66.21	68.53	80.41	87.98	93.07	118.39	109.24	81.27	114.12	132.64	172.11	150.5	102.55
Inventory to Cash Days	-15.56	-29.81	-25.32	-25.65	-22.46	-45.85	-59.36	-65.2	-28.16	-4.82	-34.42	-46.1	-49	-51.01	-54.44
Inventories	1	1	1	1	2	2	3	3	2	3	3	3	3	3	4
Raw Materials	1	1	1	1	1	1	2	2	1	2	2	2	2	1	2
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	1	1	1	1	2	1	1	1	1	1	2	2
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Market Capitalization	36	15	26	8	16	31	17	8	7	15	11	3	2	3	4
- Cash & Cash Equivalents	3	8	5	6	7	17	10	4	4	4	7	4	3	5	2
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	3	2	- -	- -	- -	- -	1	- -	1	3	1	1	1	- -	1
Enterprise Value	36	9	21	2	8	14	7	5	4	13	5	- -	-1	-2	2
Total Capital	-129	-136	-134	-142	-152	-143	-157	-169	-174	-177	-183	-189	-194	-198	-200
Total Debt/Capital (%)	-2.51	-1.42	-0.11	-0.06	-0.07	-0.29	-0.35	-0.28	-0.49	-1.51	-0.75	-0.45	-0.31	-0.15	-0.42
Total Debt / EV	0.09	0.21	0.01	0.04	0.01	0.03	0.08	0.1	0.19	0.2	0.3	2.47	-0.61	-0.13	0.41
EV/Sales	2.85	0.61	1.51	0.15	0.89	1.06	0.43	0.24	0.25	0.71	0.37	0.03	2.18	- -	0.1
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	4.15	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	3.73	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	36	15	26	8	16	31	17	8	7	15	11	3	2	3	4
Diluted Enterprise Value	36	9	21	2	8	14	7	5	4	13	5	- -	-1	-2	2
EV per Share	8,353.23	1,693.73	2,695.51	192.2	456.32	571.82	284.39	99.65	59.53	133.12	34.75	2.02	3.05	- -	1.21
TTM Sales	13	15	14	14	9	13	17	19	18	19	13	13	13	14	20
TTM EBITDA	-6	-3	-6	-6	-14	-13	-14	-11	-7	-3	-6	-4	-5	-4	-2
TTM Operating Income	-6	-3	-6	-7	-15	-13	-14	-11	-7	-3	-6	-5	-5	-4	-2
TTM Cash Flow to Firm	-3	2	-4	-7	-9	-8	-12	-12	-5	-3	-4	-6	-2	- -	-4
TTM Free Cash Flow to Firm	-3	3	-3	-7	-8	-8	-12	-12	-4	-3	-4	-6	-2	- -	-4

Multiples (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Price/Free Cash Flow	-9.85	10.9	-5.93	-1.24	-1.87	-3.94	-1.36	-0.67	-1.65	-4.64	-2.59	-0.56	-0.63	-339.72	-0.96
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	36	9	21	2	8	14	7	5	4	13	5	- -	-1	-2	2
Low Price	5,229	2,416.05	1,980	684	585	642.6	630	115.18	66.6	90.4	51	18	2.32	1.9	1.75
EV/Sales	2.85	0.61	1.51	0.15	0.89	1.06	0.43	0.24	0.25	0.71	0.37	0.03	2.18	- -	0.1
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	6.95	- -	- -	3.3	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-5.55	-4.16	6.17	-2.53	-1.85	2.3	-1.76	-1.35	-2.7	-3.71	-3	-1.52	-1.17	-1.28	-1.8
Price/Earnings High	-8.22	-7.25	13.28	-4.96	-3.19	3.8	-2.45	-3.38	-4.27	-9.9	-6.97	-2.8	-2.86	-3.36	-3.67
Price/Earnings Low	-3.1	-2.06	4.05	-0.89	-1.05	1.64	-1.11	-0.45	-1.49	-2.28	-1.33	-0.59	-0.22	-0.68	-0.93
Price/Book Value	-0.28	-0.11	-0.19	-0.06	-0.1	-0.21	-0.11	-0.05	-0.04	-0.08	-0.06	-0.02	-0.01	-0.01	-0.02
Price/Book Value Average	-0.31	-0.2	-0.17	-0.15	-0.12	-0.15	-0.16	-0.09	-0.05	-0.08	-0.08	-0.04	-0.03	-0.02	-0.03
Price/Book Value High	-0.46	-0.34	-0.37	-0.29	-0.21	-0.25	-0.22	-0.24	-0.08	-0.22	-0.19	-0.08	-0.07	-0.06	-0.06
Price/Book Value Low	-0.17	-0.1	-0.11	-0.05	-0.07	-0.11	-0.1	-0.03	-0.03	-0.05	-0.04	-0.02	-0.01	-0.01	-0.01
Price/Tangible Book Value	-41.95	3.76	2.15	0.67	1.55	1.43	1.09	0.75	1.29	2.77	1.22	0.42	0.25	0.62	1.16
Price/Tangible Book Value Average	-46.83	6.62	1.91	1.72	1.86	1	1.64	1.52	1.59	2.73	1.75	0.98	0.92	1	1.85
Price/Tangible Book Value High	-69.4	11.53	4.11	3.38	3.19	1.64	2.29	3.81	2.51	7.29	4.08	1.81	2.25	2.64	3.77
Price/Tangible Book Value Low	-26.18	3.28	1.26	0.61	1.05	0.71	1.03	0.51	0.87	1.68	0.78	0.38	0.17	0.53	0.95
Price/Sales	2.86	0.99	1.9	0.59	1.67	2.39	1	0.41	0.4	0.8	0.84	0.25	0.12	0.19	0.18
Price/Sales Average	3.19	1.75	1.69	1.5	2.01	1.66	1.51	0.84	0.5	0.79	1.21	0.59	0.45	0.31	0.29
Price/Sales High	4.73	3.04	3.63	2.94	3.46	2.75	2.11	2.1	0.79	2.1	2.81	1.09	1.09	0.81	0.6
Price/Sales Low	1.78	0.86	1.11	0.53	1.14	1.19	0.95	0.28	0.27	0.48	0.54	0.23	0.08	0.17	0.15
Price/Cash Flow	-9.03	13.33	-5.31	-1.21	-1.79	-3.75	-1.34	-0.67	-1.58	-4.39	-2.5	-0.54	-0.63	-30.88	-0.91
Price/Cash Flow Average	-10.08	23.48	-4.71	-3.1	-2.15	-2.61	-2.02	-1.36	-1.94	-4.34	-3.59	-1.27	-2.37	-50.17	-1.46
Price/Cash Flow High	-14.94	40.91	-10.15	-6.08	-3.7	-4.31	-2.82	-3.41	-3.08	-11.58	-8.34	-2.34	-5.77	-132.14	-2.96
Price/Cash Flow Low	-5.64	11.62	-3.1	-1.1	-1.22	-1.87	-1.27	-0.45	-1.07	-2.67	-1.59	-0.5	-0.44	-26.79	-0.75
Price/Free Cash Flow Average	-11	19.19	-5.26	-3.16	-2.24	-2.74	-2.05	-1.37	-2.04	-4.58	-3.71	-1.33	-2.37	-551.91	-1.53
Price/Free Cash Flow High	-16.3	33.44	-11.34	-6.21	-3.86	-4.53	-2.87	-3.44	-3.22	-12.23	-8.62	-2.45	-5.77	-1,453.52	-3.12
Price/Free Cash Flow Low	-6.15	9.5	-3.46	-1.12	-1.27	-1.96	-1.29	-0.46	-1.12	-2.82	-1.65	-0.52	-0.44	-294.74	-0.79
EV/Sales Average	3.18	1.36	1.29	1.06	1.22	0.33	0.94	0.67	0.34	0.7	0.73	0.37	0.25	- -	0.21
EV/Sales High	4.72	2.66	3.24	2.5	2.67	1.42	1.54	1.93	0.63	2.02	2.33	0.86	0.89	0.46	0.52
EV/Sales Low	1.77	0.48	0.72	0.09	0.36	22.44	0.38	0.11	0.12	0.4	0.06	0.01	1.46	- -	0.07
EV/EBITDA Average	-6.6	-6.77	-3.07	-2.29	-0.79	-0.34	-1.14	-1.17	-0.86	-4.07	-1.62	-1.09	-0.7	0.18	-1.8
EV/EBITDA High	-9.79	-13.23	-7.68	-5.41	-1.73	-1.43	-1.87	-3.4	-1.59	-11.66	-5.16	-2.58	-2.5	-1.84	-4.35
EV/EBITDA Low	-3.68	-2.38	-1.7	-0.2	-0.23	0.14	-0.46	-0.2	-0.29	-2.32	-0.13	-0.02	0.32	0.76	-0.6
EV/EBIT Average	-6.27	-6.24	-2.92	-2.2	-0.78	-0.33	-1.1	-1.13	-0.82	-3.8	-1.57	-1.06	-0.67	0.18	-1.69
EV/EBIT High	-9.3	-12.18	-7.32	-5.21	-1.7	-1.4	-1.8	-3.26	-1.53	-10.89	-5	-2.51	-2.41	-1.77	-4.1
EV/EBIT Low	-3.5	-2.19	-1.62	-0.19	-0.23	0.14	-0.45	-0.19	-0.28	-2.17	-0.13	-0.02	0.31	0.73	-0.56
Last Price	8,379	2,772	3,393	756	858.87	1,290.6	662.4	169.22	98	148.6	80.2	19.53	3.33	2.19	2.13
High Price	13,860	8,505	6,489	3,794.4	1,773	1,484.59	1,395	864	191.3	392	267.2	85	30.4	9.37	6.92
Enterprise Value Average	41	21	18	15	11	4	16	13	6	13	9	5	3	-1	4
Enterprise Value High	60	41	44	35	25	18	26	37	11	38	29	11	11	7	10
Enterprise Value Low	23	7	10	1	3	-2	6	2	2	7	1	- -	-1	-3	1

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	2
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2
Revenue per Share	2,932.35	2,793.2	1,787.6	1,291.27	512.78	540.64	661.92	410.61	242.76	186.66	95.2	78.21	27.99	11.51	11.6
EBITDA per Share	-1,413.02	-561.46	-754.25	-597.07	-791.97	-536.46	-544.35	-233.87	-95.84	-32.28	-42.98	-26.19	-9.95	-2.88	-1.38
Operating Income per Share	-1,488.03	-609.91	-791.39	-620.65	-805.32	-546.92	-563.82	-243.68	-100.07	-34.56	-44.38	-26.93	-10.33	-2.99	-1.46
Basic EPS, GAAP	-1,686.38	-1,173.72	488.49	-764.56	-556.18	390.95	-569.34	-255.37	-44.79	-39.58	-38.34	-30.35	-10.63	-2.79	-1.89
Basic EPS from Cont Ops	-1,686.38	-981.74	488.49	-764.56	-805.87	-365.44	-569.34	-255.37	-48.38	-46.24	-38.34	-30.35	-10.63	-2.79	-1.89
Diluted EPS, GAAP	-1,686.38	-1,173.72	487.34	-764.56	-556.18	390.95	-569.34	-255.37	-44.79	-39.58	-38.34	-30.35	-10.63	-2.79	-1.89
Diluted EPS from Cont Ops	-1,686.38	-981.74	487.34	-764.56	-805.87	-365.44	-569.34	-255.37	-48.38	-46.24	-38.34	-30.35	-10.63	-2.79	-1.89
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-927.75	207.88	-639.55	-623.92	-478.68	-344.28	-494.28	-253.61	-62.17	-33.85	-32.02	-36.25	-5.27	-0.07	-2.34
Free Cash Flow per Basic Share	-1,005.06	161.42	-705.47	-636.87	-497.56	-360.89	-501.71	-255.78	-64.96	-35.64	-33.06	-37.84	-5.27	-0.14	-2.45
Cash & Equivalents per Share	771.05	1,428.05	716.71	571.91	408.79	736.07	399.98	79.85	49.98	42.28	55.76	22.51	6.87	4.33	1.42
Book Value per Share	-30,445.01	-24,899.49	-17,526.68	-13,254.82	-8,339.66	-6,032.38	-6,256.02	-3,663.12	-2,374.07	-1,796.34	-1,389.83	-1,116.73	-427.14	-159.39	-119.35
Tangible Book Value per Share	-199.72	737.71	1,577.69	1,123.5	554.98	903.42	609	227.03	76.15	53.74	65.56	47.01	13.49	3.55	1.84

Sonoma Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)